3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
10
Hot Flashes
2
Anxiety Disorders
2
Vomiting
1
Testicular Germ Cell Tumor
1
Smoking Cessation
1
Sarcoma
1
Pathophobia
1
Pain
1
Ovarian Neoplasms
1
Nausea
1
Musculoskeletal Pain
1
Melanoma
1
Medication Adherence
1
Inflammatory Breast Neoplasms
1
Gastrointestinal Neoplasms
1
Emotional Regulation
1
Depression
1
Breast Carcinoma In Situ
1
Breast Cancer Surgery
1
Affective Symptoms
1
Interventions
pembrolizumab
10
Gemcitabine
8
Cyclophosphamide
7
Filgrastim
5
Docetaxel
5
Carboplatin
5
Trastuzumab
4
Surveys and Questionnaires
4
Nivolumab
4
Doxorubicin
4
Cisplatin
4
poly ICLC
3
pazopanib
3
atezolizumab
3
aldesleukin
3
Taxes
3
Radiotherapy
3
Paclitaxel
3
Oncolytic Virotherapy
3
Irinotecan
3
Ipilimumab
3
Injections
3
Drug Therapy
3
Cetuximab
3
Capecitabine
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
spartalizumab
2
palbociclib
2
liposomal doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Hypnosis
×
Breast
×
Clear all
NCT07614620
2026-05-29
HYPNO-AJA2
Institut Bergonié
Phase NA
Not yet recruiting
70 enrolled